• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery

by Fred Pennic 09/11/2024 Leave a Comment

Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery

What You Should Know:  - Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.  - The startegic partnership leverages Genesis' cutting-edge AI platform, GEMS, to accelerate drug discovery and development. A Powerful Collaboration Genesis Therapeutics' GEMS platform utilizes advanced AI techniques to generate and
Read More

Stakeholders Urge Congress and White House to Maintain Remote Prescribing Flexibilities

by Jasmine Pennic 09/11/2024 Leave a Comment

Stakeholders Urge Congress and White House to Maintain Remote Prescribing Flexibilities

What You Should Know:  - Over 330 stakeholder organizations have joined forces to call on Congress and the White House to intervene and ensure ongoing access to remote prescribing of controlled substances.  - Led by the American Telemedicine Association (ATA) and ATA Action, these organizations are concerned about the potential for the Drug Enforcement Administration (DEA) to significantly limit virtual prescribing, either through new regulations or by allowing existing
Read More

AI Shows Promise in Early Lung Cancer Detection via Chest X-rays

by Fred Pennic 09/11/2024 Leave a Comment

AI Shows Promise in Early Lung Cancer Detection via Chest X-rays

What You Should Know:  - A new study presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer offers exciting possibilities for early lung cancer detection.  - Researchers at Phrapokklao Hospital's Cancer Centre of Excellence in Bangkok, Thailand, used an AI-powered chest X-ray interpretation tool (qXR from Qure.ai) and found promising initial results.   Early Detection is Key Lung cancer has one of the
Read More

Study Reveals AI Predicts Patient Risk in Polypharmacy Seniors

by Jasmine Pennic 09/11/2024 Leave a Comment

Study Reveals AI Predicts Patient Risk in Polypharmacy Seniors

What You Should Know:  - A new study published in The American Journal of Managed Care (AJMC) highlights the potential of AI-powered technology to address the complex issue of polypharmacy in senior patients.  - The study, conducted by researchers at Brigham and Women’s Hospital, evaluated FeelBetter’s platform and found it to be highly effective in predicting medication risks and stratifying patients based on their likelihood of hospitalization or emergency department visits. The
Read More

Former FDA/Verily’s Amy Abernethy Launches Highlander Health

by Jasmine Pennic 09/10/2024 Leave a Comment

Former FDA/Verily's Amy Abernethy Launches Highlander Health

What You Should Know:  - Industry veterans Amy Abernethy, M.D., Ph.D., and Brad Hirsch, M.D., have co-founded Highlander Health, a new company dedicated to improving individualized patient care.  - The company is comprised of Highlander Health Institute, a public interest platform, and Highlander Health Partners, an investment arm. A Vision for Personalized Healthcare Dr. Abernethy and Dr. Hirsch believe that the healthcare industry needs a more integrated approach to
Read More

Hinge Health Launches Enso 3: A New FDA-Cleared Device for Chronic Pain

by Syed Hamza Sohail 09/10/2024 Leave a Comment

Hinge Health Launches Enso 3: A New FDA-Cleared Device for Chronic Pain

What You Should Know: Today, Hinge Health is announcing Enso 3™, a patented, wireless device that is FDA-cleared and clinically-proven to reduce musculoskeletal pain. One in four people with chronic pain experience sudden spikes that often disrupt their daily activities and compel them to seek relief.The new Enso 3 delivers electrical nerve stimulation that achieves non-invasive, non-addictive pain relief within minutes. First shipments of the new Enso are starting this month, with wider
Read More

Ubie’s AI Symptom Checker Outperforms Traditional Methods

by Syed Hamza Sohail 09/10/2024 Leave a Comment

Ubie's AI Symptom Checker Outperforms Traditional Methods

What You Should Know:  Ubie, a global healthcare AI platform that enhances the intersection of patients, providers, and life sciences, today announced data from Ubie Symptom Checker: A Clinical Vignette Simulation Study, which was published on medRxiv.The study evaluated the performance of Ubie’s platform using an innovative large language model-assisted (LLM) simulation method. Results show that Ubie achieved a Top-5 hit (inclusion of the correct diagnosis) accuracy of 63.4% and a
Read More

Essence SmartCare, Skyresponse Partner to Expand Ageing-In-Place Products Across Europe

by Syed Hamza Sohail 09/10/2024 Leave a Comment

Essence SmartCare, Skyresponse Partner to Expand Ageing-In-Place Products Across Europe

What You Should Know: Essence SmartCare, part of Essence Group, a global leader in IoT remote care solutions, today announced the integration of Care@Home, an end-to-end senior care solution, with leading Swedish alarm management platform Skyresponse.Under this partnership, over two million seniors across the UK, Switzerland, Nordic countries, and the DACH region will have expanded access to Care@Home, providing a fully connected care experience from initial assessment to ongoing monitoring
Read More

American Cancer Society and Yosemite Award $6M in Research Grants to Innovate Cancer Scientists

by Syed Hamza Sohail 09/10/2024 Leave a Comment

American Cancer Society and Yosemite Award $6M in Research Grants to Innovative Cancer Scientists

What You Should Know:  The American Cancer Society (ACS) and Yosemite, an oncology-focused venture capital firm, announced the selection of research grants through their Yosemite-ACS Award totaling more than $6 million.These inaugural grants will go to scientists from institutions across the country and are poised to make an impact in immuno-oncology as well as the use of Artificial Intelligence (AI) in cancer prevention, detection, treatment, and healthcare
Read More

Guardant Health Gemelli to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy

by Syed Hamza Sohail 09/10/2024 Leave a Comment

Guardant Health Gemelli to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy

What You Should Know: Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with the Agostino Gemelli University Polyclinic Foundation IRCCS (“Policlinico Gemelli”) to establish an in-house liquid biopsy testing service as a part of its diagnostics services within its hospital system. Leveraging Guardant Health’s cutting-edge proprietary digital sequencing platform, this initiative will include on-site analysis of Guardant360® CDx liquid
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 93
  • Go to page 94
  • Go to page 95
  • Go to page 96
  • Go to page 97
  • Interim pages omitted …
  • Go to page 730
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |